Lung fibrosis candidate
Pre-clinical- Indications
- Idiopathic pulmonary fibrosis
Company intelligence / Profile preview
Anima Biotech
Bernardsville, New Jersey, United Statesanimabiotech.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Preclinical
01
Overview
Anima Biotech has developed a proprietary platform that combines high-throughput phenotypic screening with artificial intelligence to discover small molecule drugs that modulate the translation of specific proteins by targeting their messenger RNA. The company has advanced a broad preclinical pipeline across multiple therapeutic areas including oncology, immunology/fibrosis, and neuroscience. Strategic partnerships with major pharmaceutical companies such as AbbVie ($42M upfront deal), Takeda ($120M+ deal), and Lilly validate the approach. No clinical-stage results have been disclosed yet; all internal programs are preclinical or earlier.
- Therapeutic areas
- OncologyPulmonologyNeurology
- Modalities
- Small molecules (specifically small molecule mRNA biology modulators)
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
AbbVie (mRNA modulators for oncology/immunology)Takeda Pharmaceuticals ($2B+ partnership in neuroscience/genetically defined neurological diseases)Eli Lilly & Co.
Beyond the preview
Go deeper on Anima Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Anima Biotech.